Intellipharmaceutics CEO moulded at Biovail U

Fifteen years ago, Dr. Isa Odidi performed magic as CSO of Biovail (NYSE:BVF; TSX:BVF), developing several blockbuster generics, including hard-to-manufacture copies of Bayer’s Adalat CC, Pfizer’s Procardia XL and Novartis’ Voltaren XR. “We have the same style here at Intellipharmaceutics (NASDAQ:IPCI; TSX:I) as we had at Biovail,” Dr. Odidi says in an exclusive interview with [...]

Arthur Higgins named to Resverlogix board

Resverlogix (TSX:RVX) has appointed Arthur Higgins, CEO of Bayer HealthCare and chairman of the Bayer HealthCare executive committee, to the board, effective Feb. 1. “Arthur Higgins’ global leadership experience and exposure to numerous healthcare markets are just a few of the reasons that he is a valued addition to the (Resverlogix) board,” CEO Donald McCaffrey [...]